RxSight, Inc. (RXST)
7.94
-0.40
(-4.80%)
USD |
NASDAQ |
Feb 04, 16:00
7.96
+0.02
(+0.25%)
After-Hours: 20:00
RxSight EPS Diluted (Quarterly) : -0.2396 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.816M |
| Revenue (Quarterly) | 30.34M |
| Total Expenses (Quarterly) | 40.16M |
| Enterprise Value | 110.51M |
| Gross Profit Margin (Quarterly) | 79.85% |
| Profit Margin (Quarterly) | -32.35% |
| Earnings Yield | -11.06% |
| Normalized Earnings Yield | -11.06 |